NASDAQConsumer StaplesBeverages - Non-alcoholicSnapshot 2026-10-23
The long-term thesis, the evidence coming in, and the environment around it. Thesis dated Jul 8, 2026.
Next-FY EPS estimate change · 30 days
A matching fiscal period and sufficient coverage are required.
One observable signal. This measures changing earnings expectations, not the probability of a gain or loss.
The calculation requires same-period, same-provider snapshots, positive EPS, at least five analysts and a baseline within three days of the requested lookback.
| Measure / period | Management expectations | Analyst expectations |
|---|---|---|
| FY 2026 · Annual | ||
| Capital expenditure | About $300M | — |
Current consensus figures unavailable.
Three published thesis conditions, with dated milestones shown separately.
| Key Factor | Why It Matters | Current Status | Break Condition | Latest Evidence |
|---|---|---|---|---|
Capex near $300 million annually | A supporting condition in Coca-Cola Consolidated's published investment case. The stated target is ~$300 million. | Intact | Capex exceeds $350 million in FY26 | Capital expenditures: $84.242M FY2026-Q2; GAAP. Published target: ~$300 million. Target period is not explicitly aligned with this observation. Source published Aug 5, 202684,242,000 USD · source valueSource reportLast status assessment Oct 24, 2026Measurement sourceconsolidated · GAAP FY2026-Q2 · Period ending Jul 3, 2026 Source: stock_quarterly_financials_fmp. Reference: 2026-Q2. Source status: unverified. Compare scope, accounting basis and period before treating this evidence as progress against an annual requirement. |
Operating income growth and margin improvement | Operating income rose 25% to $237.5 million. | Broken | Operating income growth falls below 10% YoY next year | Operating income growth: -0.27% FY2026-Q2; GAAP. Published target: >=10% YoY growth. Target period is not explicitly aligned with this observation. Source published Aug 5, 2026-0.273812 percent · calculatedSource reportLast status assessment Oct 24, 2026Measurement sourceconsolidated · GAAP FY2026-Q2 · Period ending Jul 3, 2026 Source: company_financial_results. Reference: 9115c3d0-108c-42bd-96d0-add3709e1555. Source status: eligible. Compare scope, accounting basis and period before treating this evidence as progress against an annual requirement. Management contextStated as a priority in 3 of last 3 quarters. Income from operations grew from $219M in 2024-Q4 to $242M in 2025-Q4 (+11%), then to $238M in 2026-Q1 (+25% YoY), and $509M in first half 2026 (+10% YoY). Management acknowledges cost pressures but is delivering improved operating income. Delivery assessment Oct 24, 2026 |
Revenue growth at or above 8% annually | A primary condition in Coca-Cola Consolidated's published investment case. The stated target is >=8% YoY. | Intact | YoY revenue growth falls below 8% next year | Revenue growth: 10.61% FY2026-Q2; GAAP. Published target: >=8% YoY. Target period is not explicitly aligned with this observation. Source published Aug 5, 202610.61164 percent · calculatedSource reportLast status assessment Oct 24, 2026Measurement sourceconsolidated · GAAP FY2026-Q2 · Period ending Jul 3, 2026 Source: company_financial_results. Reference: 9115c3d0-108c-42bd-96d0-add3709e1555. Source status: eligible. Compare scope, accounting basis and period before treating this evidence as progress against an annual requirement. |
Stored thesis · Jul 8, 2026. Latest Evidence uses source-matched measurements where available, alongside the last thesis-monitor assessment. Source periods and assessment dates are shown separately. A new measurement does not automatically change the published status or verify an older target.
Compare these dated observations with the operating requirements above
Comparable estimate history is unavailable.
Revenue and EPS estimates track expectations. They are not delivered results or like-for-like proof of a required annual path.
Compare required revenue and earningsMonthly analyst history is unavailable.
Recent actions · Sep 25–Oct 24 · 0 recorded
Individual price-target observations are unavailable.
0 raises · 0 cuts · 0 unchanged · 0 without a comparable prior
Sep 25, 2026–Oct 24, 2026. Each firm's latest positive target is paired only with its immediately prior positive target from the same provider, at most 180 days earlier. Unmatched observations have one dot; conflicting observations are not compared.
The evidence, the remaining questions, and what comes next
No recovery evidence is reported in the available driver assessments.
Nov 4, 2026
Look for updated results and guidance against the published targets, plus direct evidence for unresolved drivers.
Review earnings3 of 3 published conditions remain under pressure or need verification. The next results need to address those conditions.
The dated weekly assessment and its assumptions are available in Read detailed Outlook.
Observed price history; separate from operating scenarios
The weekly editorial context below is a separate assessment from the dated monitor evidence above. Recovery observations do not automatically change the published thesis. Unverified outside influences are hypotheses, not measured driver evidence.
COKE is a growth-oriented consumer staples business with a multi-year view that depends on continued volume growth and cost control. The thesis is intact, though confidence has eased from high to medium and the next earnings report is a key near-term check.
COKE is valued at a 1.48 premium to peers, and the evidence rates it expensive. The priced-in assessment is tagged justified, but the expectations gap is negative, so valuation already reflects meaningful expectations and leaves room for disappointment if execution weakens.
Near term, revenue and volume growth have improved, operating income has grown, and management remains on track with its stated priorities, including planned capital spending. However, the company and its industry peers have recently missed earnings, and the next report carries a meaningful risk of a guidance cut. Over the multi-year view, continued growth depends on sustaining volume gains while managing cost pressures.
The unfavorable case is a guidance cut or further weakening in job growth, which could increase recession concerns for cyclical businesses. The favorable case is continued strong results and higher guidance from sector bellwethers such as KO, PEP, and MNST, supporting sector momentum. The central swing factor is whether COKE can keep delivering growth without letting costs or earnings misses weaken confidence.
Over the next 1 to 3 years, COKE’s long-term thesis rests on ongoing revenue and volume growth, disciplined spending, and better operating income, set against expensive valuation and near-term earnings risk. Not investment advice.
Not investment advice. Scores describe historical and current data; they are not forecasts of future returns. Consult a licensed advisor before making investment decisions.